JPMorgan Chase & Co’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.83K | Sell |
|
|||||
|
2025
Q2 | $6.59K | Sell |
|
|||||
|
2025
Q1 | $55.1K | Buy |
|
|||||
|
2024
Q4 | $120K | Buy |
|
|||||
|
2024
Q3 | $147K | Buy |
|
|||||
|
2024
Q2 | $115K | Buy |
|
|||||
|
2024
Q1 | $49 | Sell |
|
|||||
|
2023
Q4 | $38.9K | Sell |
|
|||||
|
2023
Q3 | $17K | Buy |
|
|||||
|
2023
Q2 | $4.13K | Sell |
|
|||||
|
2023
Q1 | $107K | Sell |
|
|||||
|
2022
Q4 | $592K | Buy |
|
|||||
|
2022
Q3 | $231K | Buy |
|
|||||
|
2022
Q2 | $187K | Sell |
|
|||||
|
2022
Q1 | $1.68M | Buy |
|
|||||
|
2021
Q4 | $925K | Sell |
|
|||||
|
2021
Q3 | $2.45M | Buy |
|
|||||
|
2021
Q2 | $625K | Buy |
|
|||||
|
2021
Q1 | $230K | Buy |
|
|||||
|
2020
Q4 | $159K | Buy |
|